Advertisement

Picture Berlin Partner Voices Tim Huse BIH Digital Health 650x100px
Document › Details

Bayer AG. (7/31/19). "Press Release: U.S. FDA Approves Darolutamide, a New Treatment for Men with Non-metastatic Castration-resistant Prostate Cancer [Not intended for U.S. and UK Media]". Berlin.

Region Region United States (USA)
Organisations Organisation Bayer AG
  Group Bayer (Group)
  Organisation 2 FDA (US Food and Drug Administration)
  Group United States (govt)
Products Product Nubeqa®
  Product 2 phase 3 study
Person Person LaCaze, Robert (Bayer 201702–202202 EVP of new Oncology Strategic Business Unit joined 2015 from BMS LEFT 2/22)
     


   
Record changed: 2023-06-05

Advertisement

Picture EBD Group BIO-Europe 2024 Stockholm from 14 Sep 650x200px

More documents for Bayer (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Consultech GmbH Secure Funding with RnD Grants 650x300px




» top